Whilst biallelic NF2 gene inactivation is an absolute requirement for schwannoma growth in addition to biallelic SMARCB1 mutation, complete NF2 gene inactivation is dispensable for MRT development. This evidence concerns the gene SMARCB1 and schwannoma.